+29.1%
MRNA vs GPC
-1.9%
+31.0%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GPC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -0.8% | +1.5% | +1.2% |
| 7D | -8.2% | -1.8% | -6.5% | -7.3% |
| 30D | +125.6% | +0.1% | +125.5% | +126.6% |
| 3M | +197.1% | +37.4% | +159.7% | +161.1% |
| 6M | +148.5% | +25.4% | +123.1% | +125.8% |
| YTD | +363.3% | +12.2% | +351.1% | +327.9% |
| 1Y | +462.0% | -0.3% | +462.3% | +449.0% |
| All | +29.1% | -1.9% | +31.0% | +18.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GPC.
Daily Out/Under-Performance
Portfolio return minus GPC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GPC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GPC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling